BZBailey B. Zeiler

Bailey B. Zeiler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bailey B. Zeiler has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantifying the decline in fetal hemoglobin following adult red blood cell transfusions in preterm infants

    by Timothy Bahr, Bailey Zeiler, Rachel Maxfield, Elizabeth Stone, Joel Addams, Scott Potter, Robin Ohls, Robert Christensen

    OBJECTIVE: To quantify the effect of transfusing preterm neonates with 20 mL/kg adult red blood cells (RBCs) on fetal hemoglobin (HbF%) and examine associations with outcomes. STUDY DESIGN: We retrospectively analyzed HbF% before vs. after RBC transfusions and investigated associations with retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD). RESULTS: HbF% in 1147 non-transfused infants were compared with pre- vs . post-transfusion values from 23 transfused infants. Each initial transfusion decreased HbF% from normal (mean= 91% , 95%CI, 86-96%) to abnormal ( 49% , 95%CI, 42-56%, p<0.001). Multiple transfusions progressively decreased HbF% (p<0.001). Infants receiving ≥40 mL/kg before 30 weeks postmenstrual age (PMA) were more likely to develop severe ROP and BPD. CONCLUSIONS: Adult RBC transfusion substantially reduces HbF% in preterm neonates. Low HbF% before 30 weeks PMA is associated with severe ROP and BPD. Serially measuring HbF% warrants evaluation as a surrogate endpoint in clinical trials comparing umbilical cord blood vs. adult RBC transfusions.

  • Establishing reference intervals for fetal hemoglobin percentage from 23 to 40 weeks of gestation using refineR

    by Bailey B. Zeiler, Timothy M. Bahr, Kelly Doyle, Rachel E. Maxfield, Elizabeth F. Stone, Joel L. Addams, Robin K. Ohls, Robert D. Christensen


  • Redefining neonatal thrombocytopenia: an evidence-based approach, improved by the refineR algorithm

    by Bailey B. Zeiler, Timothy M. Bahr, Kelly Doyle, Erick Henry, Lindsey C. Carlson, Patricia Davenport, Martha C. Sola-Visner, Robin K. Ohls, Robert D. Christensen

  • Open Access

    The risk of developing severe bronchopulmonary dysplasia: evaluating associations with the nucleated red blood cell count at birth and volume of transfusions received

    by Bailey B. Zeiler, Timothy M. Bahr, Khanh V. Lai, Joel L. Addams, Elizabeth F. Stone, Erica A. Swenson, Robin K. Ohls, Robert D. Christensen

    Introduction: The nucleated red blood cell (NRBC) count at birth and blood transfusions received prior to 36 weeks postmenstrual age (PMA) are both associated with the risk of developing retinopathy of prematurity (ROP). We examined the association of these two factors with the risk of developing bronchopulmonary dysplasia (BPD). Methods: We retrospectively analyzed records of infants in five Intermountain Health Neonatal Intensive Care Units during the past four years who were born refineR algorithm. We report red blood cell (RBC) and platelet transfusions received before 36 weeks PMA. Results: The NRBC count of 896 infants was not independently associated with BPD risk. However, RBC transfusions received before 36 weeks were associated with BPD risk ( p < 0.01). All 39 infants who developed severe BPD received multiple RBC transfusions (volume range 36–501 mL/kg) and 15 (38%) also received platelet transfusions (range 16–489 mL/kg). Conclusions: An elevated NRBC count at birth is not an independent risk factor for developing severe BPD, but the number and volume of RBC transfusions received are associated factors.


  • A CBC drawn postnatally from umbilical cord blood can provide valuable diagnostic information for infants admitted to the NICU

    by Robert D. Christensen, Timothy M. Bahr, Bailey B. Zeiler, Stephen D. Minton, Catherine L. Chang, Jessica Davidson, Sara J. Ilstrup, Patrick D. Carroll, David A. Kaufman, Robin K. Ohls

    A complete blood cell count (CBC) characterizes the cellular components of blood. It is one of the most frequently performed blood tests of hospitalized patients, including infants in a NICU. We quantified the percentage of Intermountain Health NICU patients who, during the past ten years, had a CBC drawn at birth or within the first two hours thereafter. The percentage progressively dropped annually, from 54% in 2016 to 13% in 2025. We authored this Perspective, (1) to review the array of diagnostic information that can be gained by a CBC at NICU admission, and (2) to emphasize that the initial CBC can be drawn from otherwise discarded fetal blood in the umbilical cord. Using that method avoids the blood volume reduction, and the pain, associated with infant phlebotomy. We hope these reminders support NICU providers in making informed decisions about ordering a CBC at birth.

  • Designing and implementing a clinical decision support tool to improve compliance with NICU transfusions

    by Ameena N. Husain, Amanda Drury, Erica A. Swenson, Ryan A. Metcalf, Kelly Cail, Kensaku Kawamoto, Catherine L. Chang, Bailey B. Zeiler, Timothy M. Bahr, Robin K. Ohls, et al.

    Infants in a neonatal intensive care unit (NICU), out of all hospitalized patients, are among those with the highest likelihood of receiving blood products. Because liberal transfusion strategies can be harmful, transfusion risks should be weighed against potential benefits. In the adult population, implementing electronic clinical decision support (CDS) tools for transfusion have resulted in decreased transfusion rates, conservation of resources, and lower costs. The NICU at the University of Utah Hospital has transfusion guidelines, but a recent audit indicated that a considerable proportion of transfusions were not compliant. Clinicians indicated that one reason for guideline deviation is not having guidelines immediately available in a timely reminder during the transfusion ordering process. Therefore, we built a new electronic transfusion CDS tool for our NICU. To our knowledge, this is the first report of an electronic health record-based CDS tool for both red blood cell and platelet transfusions in a NICU.


  • Open Access

    Transfusion Histories of Neonates Who Developed Severe Retinopathy of Prematurity

    by Bailey B. Zeiler, M. Elizabeth Hartnett, Joel L. Addams, Elizabeth F. Stone, Sarah J. Ilstrup, Timothy M. Bahr, Robin K. Ohls, Robert D. Christensen

    Introduction: The recent BORN study suggests the incidence of retinopathy of prematurity (ROP) might be significantly reduced by transfusing extremely low gestational age neonates (ELGANs) with red blood cells (RBCs) not from adult donors, but from umbilical cord blood. We are uncertain what proportion of infants with severe ROP had no RBC transfusions and thus would not benefit from changing transfusion practice. Methods: We created detailed transfusion histories of all infants in our health system (2021–2024) who developed severe ROP. Results: Severe (stage ≥3) ROP was diagnosed in 34 infants; 32 of these had received 1–18 RBC transfusions. Eleven also received 1–16 platelet transfusions. Two received no transfusions. Conclusion: A small minority of infants with severe ROP were never transfused, thus changing transfusion practice would not likely prevent all cases. However, the great majority had multiple RBC transfusions and thus might benefit from cord blood RBC transfusions.


  • Reference intervals for circulating nucleated red blood cell counts of neonates, improved by the refineR algorithm

    by Robert D. Christensen, Kelly Doyle, Erick Henry, Sterling T. Bennett, Bailey B. Zeiler, Sarah J. Ilstrup, Erica A. Swenson, Timothy M. Bahr, Robin K. Ohls

    Background A “high” concentration of nucleated red blood cells (NRBC) in the blood of neonates at birth has been used as a biomarker of fetal hypoxia and a risk factor for poor outcome. Previous neonatal reference intervals for NRBC counts were likely contaminated by high counts from neonates born after unrecognized fetal hypoxia. We hypothesized that a new method for creating reference intervals, refineR, would produce more accurate physiological intervals for neonatal NRBC counts. Study design We utilized refineR and real-world multicentered data from Intermountain Health to create new neonatal NRBC count reference intervals. Results Using 4 ½ years of multi-hospital data, refineR created reference interval charts for NRBC counts at birth and over the first days. The new intervals are narrower than the previous version, with lower median and upper-limit values. Conclusion With the new charts, clinicians can more confidently assess whether a neonate’s NRBC count is normal vs. elevated.


  • Open Access

    Kernicterus Continues to Occur in the USA Despite Concerted Preventive Efforts

    by Bailey B. Zeiler, Timothy M. Bahr, Robin K. Ohls, Robert D. Christensen

    Kernicterus spectrum disorder continues to occur in the USA, even after improvements in detecting and managing hyperbilirubinemia were brought about by the 2022 AAP revised guidelines. Three of eight new cases of kernicterus occurring in our state during the past 15 years were infants who were intentionally born at home following a low‐risk term pregnancy where the AAP guidelines were not applied. Considering the number of births per year in each setting, infants born at home are 7 times more likely to develop kernicterus than infants born in a hospital. Herein, we report our most recent case. We then provide a practical recommendation for averting future cases of kernicterus following out‐of‐hospital births. Specifically, we recommend that hospital systems and/or health departments supply all midwives performing out‐of‐hospital births with the equipment and training necessary to comply with the AAP guidelines by quantitatively assessing hyperbilirubinemia on every neonate 24–48 h following birth. We propose that this noninvasive, simple, and rapid assessment should be free of charge to the midwife and to the family. We maintain that if this is done routinely after every out‐of‐hospital birth, it will identify the neonates who need phototherapy and who sometimes also need other medical care to prevent extreme hyperbilirubinemia. We believe that such a program will prevent acute bilirubin encephalopathy and kernicterus and that without such a program, the dreadful condition of kernicterus spectrum disorder will continue to occur among our population of infants born at home.